FIBROLAMELLAR CARCINOMA
Clinical trials for FIBROLAMELLAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIBROLAMELLAR CARCINOMA trials appear
Sign up with your email to follow new studies for FIBROLAMELLAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough liver cancer: immune therapy trial opens
Disease control Recruiting nowThis study is testing whether an immunotherapy drug called pembrolizumab (KEYTRUDA®) can help control liver cancer that has come back or hasn't responded to other treatments in children and young adults. The trial will enroll up to 18 participants under age 30 to see if the drug …
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE2 • Sponsor: Allison O'Neill, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for kids with tough cancers: Four-Drug combo trial opens
Disease control Recruiting nowThis study is testing a new combination of four medicines for children and young adults (under 30) whose solid tumors have come back or haven't responded to standard treatments. The first part checks if the drug mix is safe and finds the right dose. The second part sees how well …
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC